Itau Unibanco Holding S.A.’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-58
Closed -$13.7K – 176
2023
Q4
$13.7K Sell
58
-13
-18% -$2.56K ﹤0.01% 297
2023
Q3
$13.9K Sell
71
-763
-91% -$157K ﹤0.01% 400
2023
Q2
$175K Buy
834
+49
+6% +$9.75K 0.01% 187
2023
Q1
$158K Buy
+785
New +$178K 0.01% 193
2021
Q4
– Sell
-224
Closed -$92K – 423
2021
Q3
$92K Buy
224
+78
+53% +$32.4K ﹤0.01% 195
2021
Q2
$54K Buy
+146
New +$48.8K ﹤0.01% 163
2018
Q3
– Sell
-1,256
Closed -$141K – 635
2018
Q2
$141K Sell
1,256
-3,569
-74% -$386K 0.01% 441
2018
Q1
$515K Sell
4,825
-753
-13% -$81.2K ﹤0.01% 211
2017
Q4
$611K Buy
5,578
+1,656
+42% +$180K 0.04% 145
2017
Q3
$1.34M Buy
3,922
+3,572
+1,021% +$367K 0.09% 125
2017
Q2
$35K Buy
350
+20
+6% +$1.84K ﹤0.01% 334
2017
Q1
$30K Buy
330
+210
+175% +$17.8K ﹤0.01% 309
2016
Q4
$9K Buy
+120
New +$9.11K ﹤0.01% 277

Other funds holding CRL

Itau Unibanco Holding S.A.'s CRL Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 58 shares — an estimated $13.7K sold.

Itau Unibanco Holding S.A. first reported a position in CRL in Q4 2016 and held it in 13 quarters. The position peaked at $1.34M in Q3 2017. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Itau Unibanco Holding S.A. reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 58 Charles River Laboratories shares in Q1 2024, an estimated $13.7K.
  • Itau Unibanco Holding S.A. first reported a position in Charles River Laboratories in Q4 2016 and held it in 13 quarters.
  • Itau Unibanco Holding S.A.'s Charles River Laboratories position peaked at $1.34M in Q3 2017.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.